TANNENBAUM RENEE P 4

What Happened
Renee P. Tannenbaum, a director of ANI Pharmaceuticals, was granted a restricted stock award of 4,357 shares on May 21, 2026. The shares were issued at $0.00 (code A — award/grant), so no cash was exchanged. The award will vest in full on May 21, 2027 per the filing footnote.

Key Details

• Transaction date: 2026-05-21 (Form 4 filed 2026-06-10). The filing appears late relative to the 2-business-day Form 4 deadline.
• Transaction type/code: Award/Grant (A).
• Shares granted: 4,357; acquisition price reported $0.00 (no cash paid).
• Vesting: The award vests in full on May 21, 2027 (Footnote F1).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Accession / filing: Accession No. 0001543174-26-000003; Period of Report 2026-05-21.

Context
Restricted stock awards are a form of compensation that typically vest over time and may be forfeited if conditions are not met; they are different from open-market purchases and do not by themselves indicate immediate bullish insider buying. The grant establishes a potential future economic interest for the director once the award vests.